Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Vandenbroucke

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Virological Methods|May 10, 2011
HIV-1 nucleotide mixture detection in the virco(®)TYPE HIV-1 genotyping assay: a comparison between Sanger sequencing and 454 pyrosequencingHans De Wolf, Herwig Van Marck, Wendy Mostmans, et al.
Biotechniques|September 13, 2011
Minor variant detection in amplicons using 454 massive parallel pyrosequencing: experiences and considerations for successful applicationsIna Vandenbroucke, Herwig Van Marck, Peter Verhasselt, et al.
Journal of Virology|August 27, 2010
Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencingThierry Verbinnen, Herwig Van Marck, Ina Vandenbroucke, et al.
Virology|February 7, 2012
Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patientsPeter Messiaen, Chris Verhofstede, Ina Vandenbroucke, et al.
Gastroenterology|August 14, 2012
Efficacy of re-treatment with TMC435 as combination therapy in hepatitis C virus-infected patients following TMC435 monotherapyOliver Lenz, Joep de Bruijne, Leen Vijgen, et al.
AIDS Research and Therapy|September 1, 2010
HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assaysIna Vandenbroucke, Herwig Van Marck, Wendy Mostmans, et al.
Antiviral Research|February 26, 2011
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitroValentina Svicher, Emanuela Balestra, Valeria Cento, et al.
The Journal of Infectious Diseases|January 13, 2012
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencingDaniele Armenia, Ina Vandenbroucke, Lavinia Fabeni, et al.
The Journal of Antimicrobial Chemotherapy|January 4, 2011
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatmentLinos Vandekerckhove, Chris Verhofstede, Els Demecheleer, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Virological Methods|May 10, 2011
HIV-1 nucleotide mixture detection in the virco(®)TYPE HIV-1 genotyping assay: a comparison between Sanger sequencing and 454 pyrosequencingHans De Wolf, Herwig Van Marck, Wendy Mostmans, et al.
Biotechniques|September 13, 2011
Minor variant detection in amplicons using 454 massive parallel pyrosequencing: experiences and considerations for successful applicationsIna Vandenbroucke, Herwig Van Marck, Peter Verhasselt, et al.
Journal of Virology|August 27, 2010
Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencingThierry Verbinnen, Herwig Van Marck, Ina Vandenbroucke, et al.
Virology|February 7, 2012
Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patientsPeter Messiaen, Chris Verhofstede, Ina Vandenbroucke, et al.
Gastroenterology|August 14, 2012
Efficacy of re-treatment with TMC435 as combination therapy in hepatitis C virus-infected patients following TMC435 monotherapyOliver Lenz, Joep de Bruijne, Leen Vijgen, et al.
AIDS Research and Therapy|September 1, 2010
HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assaysIna Vandenbroucke, Herwig Van Marck, Wendy Mostmans, et al.
Antiviral Research|February 26, 2011
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitroValentina Svicher, Emanuela Balestra, Valeria Cento, et al.
The Journal of Infectious Diseases|January 13, 2012
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencingDaniele Armenia, Ina Vandenbroucke, Lavinia Fabeni, et al.
The Journal of Antimicrobial Chemotherapy|January 4, 2011
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatmentLinos Vandekerckhove, Chris Verhofstede, Els Demecheleer, et al.
Pageof 2